Staphylococcal toxic shock syndrome in a child. Case report
DOI: 10.32364/2618-8430-2021-4-3-302-307
G.S. Karpovich1,2, I.V. Kuimova1, E.I. Krasnova1, D.S. Maramygin2, A.Yu. Enikeev2
1Novosibirsk State Medical University, Novosibirsk, Russian Federation
2Children’s City Clinical Hospital No. 3, Novosibirsk, Russian Federation
Toxic shock syndrome (TSS) is a complex of symptoms that includes fever, exanthem, multiple organ dysfunction syndrome, and hypotension. The most common causative agents are S. aureus and group A Streptococcus. TSS is characterized by severe course and high mortality in the lack of specific complex treatment. This article addresses a case report of staphylococcal TSS in a 5-year-old girl. The primary focus of infection (infected right leg wound) and breakthrough factors (the lack of adequate wound care) resulted in the dissemination of causative agent and TSS development. Despite disease severity, early complex etiological (antibiotics) and pathogenically-oriented (infusions, corticosteroids) treatment improved the patient’s condition and promoted recovery. This case report illustrating the classic presentations of staphylococcal TSS in children is helpful for pediatricians in terms of awareness of this pathological condition.
Keywords: infectious diseases, staphylococcus aureus, toxic shock syndrome, cytokine storm, multiple organ failure syndrome, pediatrics.
For citation: Karpovich G.S., Kuimova I.V., Krasnova E.I. et al. Staphylococcal toxic shock syndrome in a child. Case report. Russian Journal of Woman and Child Health. 2021;4(3):302–307 (in Russ.). DOI: 10.32364/2618-8430-2021-4-3-302-307.
2. Hans D., Kelly E., Wilhelmson K., Katz E.D. Rapidly fatal infections. Emerg Med Clin North Am. 2008;26(2):259–279. DOI: 10.1016/j.emc.2008.01.003.
3. Dayan G.H., Mohamed N., Scully I.L. et al. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Rev Vaccines. 2016;15(11):1373–1392. DOI: 10.1080/14760584.2016.1179583.
4. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978;2(8100):1116–1118. DOI: 10.1016/s0140-6736(78)92274-2.
5. Reingold A.L., Hargrett N.T., Shands K.N. et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982;96(6 Pt 2):875.
6. Davis J.P., Chesney P.J., Wand P.J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980;303:1429.
7. Centers for Disease Control (CDC). Update: toxic-shock syndrome-United States. MMWR Morb Mortal Wkly Rep. 1983;32:398.
8. Osterholm M.T., Davis J.P., Gibson R.W. et al. Toxic shock syndrome: relation to catamenial products, personal health and hygiene, and sexual practices. Ann Intern Med. 1982;96:954.
9. Sharma H., Smith D., Turner C.E. et al. Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom. Emerg Infect Dis. 2018;24(2):258–266. DOI: 10.3201/eid2402.170606.
10. Costa Orvay J.A., Caritg Bosch J., Morillo Palomo A. et al. [Toxic shock syndrome: experience in a pediatric intensive care unit]. UCIP. An Pediatr (Barc). 2007;66(6):566–572 (in Spanish). DOI: 10.1157/13107390.
11. Javouhey E., Pierre-Adrien Bolze, Claire Jamen C. et al. Similarities and differences between staphylococcal and streptococcal toxic shock syndromes in children: results from a 30-case cohort. Front Pediatr. 2018;6:360. DOI: 10.3389/fped.2018.00360.
12. Adalat S., Dawson T., Hackett S.J., Clark J.E. In association with the British Paediatric Surveillance Unit. Toxic shock syndrome surveillance in UK children. Arch Dis Child. 2014;99:1078–1082. DOI: 10.1136/archdischild-2013-304741.
13. Stich N., Waclavicek M., Model N., Eibl M.M. Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm. Toxins (Basel). 2010;2(9):2272–2288. DOI: 10.3390/toxins2092272.
14. Becker R.E., Berube B.J., Sampedro G.R. et al. Tissue-specific patterning of host innate immune responses by Staphylococcus aureus a-toxin. J Innate Immun. 2014;6(5):619–631. DOI: 10.1159/000360006.
15. Козлов В.К. Цитокинотерапия: патогенетическая направленность при инфекционных заболеваниях и клиническая эффективность. СПб.; 2010. [Kozlov V.K. Cytokine therapy: pathogenetic orientation in infectious diseases and clinical efficacy. St. Petersburg; 2010 (in Russ.)].
16. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Eng J Med. 2003;348(2):138–150. DOI: 10.1056/NEJMra021333.
17. Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med. 2008;26(6):711–715.
18. Kaplan S.L. Staphylococcus aureus infections in children: the implications of changing trends. Pediatrics. 2016;137(4):e20160101. DOI: 10.1542/peds.2016-0101.
19. Rayala B.Z., Morrell D.S. Common skin conditions in children: skin infections. FP Essent. 2017;453:26–32.
20. Schmitz M., Roux X., Huttner B., Pugin J. Streptococcal toxic shock syndrome in the intensive care unit. Ann Intensive Care. 2018;8(1):88.
21. Lappin E., Ferguson A.J. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9(5):281–290.
22. Robinson K.A., Rothrock G., Phan Q. et al. Active bacterial core surveillance/emerging infections program network. Risk for severe group A streptococcal disease among patients’ household contacts. Emerg Infect Dis. 2003;9(4):443–447.
23. Краснова Е.И., Карпович Г.С., Васюнин А.В. и др. Особенности клинико-лабораторных показателей в различные периоды псевдотуберкулезной инфекции у детей на территории Новосибирской области. Лечащий врач. 2020;23(11):40–45. [Krasnova E.I., Karpovich G.S., Vasyunin A.V. and other. Features of clinical and laboratory parameters in different periods of pseudotuberculosis infection in children in the Novosibirsk region. Attending doctor. 2020;23(11):40–45 (in Russ.)]. DOI: 10.26295 / OS.2020.68.84.009.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать